Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 1, 2011, Pages 78-84

  Cushing, Sharon L ^a,b   Boucek, Robert J ^a   Manning, Scott C ^a,b   Sidbury, Robert ^a   Perkins, Jonathan A ^a,b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hemangioma; Pediatrics; Propranolol; Vascular malformations

Indexed keywords

PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; DIET RESTRICTION; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFANT; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SOCIAL ASPECT; TERTIARY HEALTH CARE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; HEAD AND NECK TUMOR; HEMANGIOMA; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEART RATE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; OUTPATIENTS; PROPRANOLOL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79959592562     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810390445     Document Type: Article

References (34)

1. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341:173-181. (Pubitemid 29325746)
2. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138: 1567-1576. (Pubitemid 35453469)
3. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150:291-294. (Pubitemid 46328964)
4. Bennett ML, Fleischer AB Jr, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137:1208-1213. (Pubitemid 32847844)
5. Perkins JA, Duke W, Chen E, et al. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol Head Neck Surg. 2009;141:207-212.
6. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649-2651. (Pubitemid 351831393)
7. Leaute-Labreze C, Taieb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol. 2008;135:860-862.
8. Bonifazi E, Colonna V, Mazzota F, et al. Propranolol in rapidly growing hemangiomas. Eur J Pediat Dermatol. 2008;18:185-192.
9. Buckmiller LM, Munson PD, Dyamenahalli U, et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010;120:676-681.
10. Pickoff AS, Zies L, Ferrer PL, et al. High-dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr. 1979;94:144-146. (Pubitemid 9036158)
11. Artman M, Grayson M, Boerth RC. Propranolol in children: safety-toxicity. Pediatrics. 1982;70:30-31. (Pubitemid 12078070)
12. Baron PW, Barrow RE, Pierre EJ, et al. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil. 1997;18:223-227. (Pubitemid 27215314)
13. Kallen RJ, Mohler JH, Lin HL. Hypoglycemia: a complication of treatment of hypertension with propranolol. Clin Pediatr (Phila). 1980;19:567-568. (Pubitemid 10087468)
14. McBride JT, McBride MC, Viles PH. Hypoglycemia associated with propranolol. Pediatrics. 1973;51:1085-1087.
15. Tomlinson B, Cronin CJ, Graham BR, et al. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol. J Cardiovasc Pharmacol. 1987;10(suppl 11):S69-S75.
16. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol. 2009;26:642-644.
17. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359:2846.
18. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610-614.
19. Hospital TJH. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 14th ed. St Louis, MO: Mosby-Year; 1996.
20. Nadas AS, Fyler DS. Pediatric Cardiology. 3rd ed. Philadelphia, PA: WB Saunders; 1972.
21. Shaddy RE, Curtin EL, Sower B, et al. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. Am Heart J. 2002;144:383-389.
22. Butani L, Morgenstern BZ. Are pitfalls of oxcillometric blood pressure measurements preventable in children? Pediatr Nephrol. 2003;18:313-318. (Pubitemid 36790067)
23. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
24. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171-1179. (Pubitemid 47403103)
25. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649-2651. (Pubitemid 351831393)
26. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171-1179. (Pubitemid 47403103)
27. Harrison DC, Meffin PJ, Winkle RA. Clinical pharmacokinetics of antiarrhythmic drugs. Prog Cardiovasc Dis. 1977;20:217-242. (Pubitemid 8233424)
28. Tomlinson B, Cronin CJ, Graham BR, et al. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol. J Cardiovasc Pharmacol. 1987;10(suppl 11):S69-S75.
29. Greenblatt DJ, Koch-Weser J. Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Am Heart J. 1973;86: 478-484.
30. Nies AS, Shand DG. Clinical pharmacology of propranolol. Circulation. 1975;52:6-15.
31. Maisel AS, Motulsky HJ, Insel PA. Propranolol treatment externalizes beta-adrenergic receptors in guinea pig myocardium and prevents further externalization by ischemia. Circ Res. 1987;60:108-112. (Pubitemid 17056936)
32. Aarons RD, Nies AS, Gal J, et al. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980;65:949-957.
33. Bush GH, Steward DJ. Severe hypoglycaemia associated with preoperative fasting and intraoperative propranolol: a case report and discussion. Paediatr Anaesth. 1996;6:415-417. (Pubitemid 126444260)
34. Chavez H, Ozolins D, Losek JD. Hypoglycemia and propranolol in pediatric behavioral disorders. Pediatrics. 1999;103: 1290-1292. (Pubitemid 29258809)